VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
DVADaVita Inc.
$207.91$13.3B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
  1. Home
  2. Financial Ratios

  1. Home
  2. DVA
  3. Financial Ratios

DaVita Inc. (DVA) Financial Ratios

30 years of historical data (1996–2025) · Healthcare · Medical - Care Facilities

View Quarterly Ratios →

P/E Ratio
↓
21.86
↑+66% vs avg
5yr avg: 13.17
079%ile100
30Y Low11.2·High105.5
View P/E History →
EV/EBITDA
↓
10.14
+13% vs avg
5yr avg: 9.00
067%ile100
30Y Low2.5·High18.0
P/FCF
↓
10.18
↑+27% vs avg
5yr avg: 8.05
037%ile100
30Y Low5.3·High23.9
P/B Ratio
↑
15.81
↑+194% vs avg
5yr avg: 5.39
097%ile100
30Y Low1.6·High23.1
ROE
↑
46.0%
↓+32% vs avg
5yr avg: 34.8%
090%ile100
30Y Low-34%·High81%
Debt/EBITDA
↑
5.52
+10% vs avg
5yr avg: 5.02
093%ile100
30Y Low0.2·High7.1

Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.

DVA Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

DaVita Inc. trades at 21.9x earnings, 66% above its 5-year average of 13.2x, sitting at the 79th percentile of its historical range. This is roughly in line with the Healthcare sector median P/E of 22.1x. On a free-cash-flow basis, the stock trades at 10.2x P/FCF, 27% above the 5-year average of 8.0x.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$13.3B$10.0B$13.1B$9.8B$7.2B$12.5B$14.4B$11.5B$8.9B$13.8B$13.2B
Enterprise Value$27.6B$24.3B$24.3B$20.5B$18.7B$24.0B$25.3B$21.6B$18.6B$22.7B$21.4B
P/E Ratio →21.8611.9513.9414.1213.0812.7818.3714.2411.2420.8214.97
P/S Ratio0.980.731.020.800.621.081.251.010.781.270.89
P/B Ratio15.818.646.243.563.225.284.973.301.762.342.26
P/FCF10.187.648.906.557.459.7011.048.8411.3113.7911.60
P/OCF7.085.316.454.744.576.487.275.575.017.256.70

P/E links to full P/E history page with 30-year chart

DVA EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

DaVita Inc.'s enterprise value stands at 10.1x EBITDA, 13% above its 5-year average of 9.0x. The Healthcare sector median is 14.2x, placing the stock at a 29% discount on an enterprise-value basis.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—1.781.901.691.612.072.191.901.642.081.45
EV / EBITDA10.148.918.648.739.049.6910.879.578.819.558.41
EV / EBIT13.7512.6112.1613.0114.1613.3215.5713.1912.1412.3810.48
EV / FCF—18.5416.5913.7519.4918.6319.3716.5523.7722.6018.82

DVA Profitability

Margins and return-on-capital ratios measuring operating efficiency

DaVita Inc. earns an operating margin of 14.7%. Operating margins have expanded from 13.2% to 14.7% over the past 3 years, signaling improving operational efficiency. Return on equity of 46.0% is exceptionally high. ROIC of 10.5% represents solid returns on invested capital.

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin27.0%27.0%32.9%31.5%29.3%31.4%30.8%30.5%28.1%29.8%22.2%
Operating Margin14.7%14.7%16.3%13.2%11.5%15.5%14.7%14.4%13.4%16.7%13.8%
Net Profit Margin5.5%5.5%7.3%5.7%4.8%8.4%6.7%7.1%1.4%6.1%6.0%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE46.0%46.0%38.7%27.8%24.4%37.1%24.2%19.0%2.9%11.3%14.9%
ROA4.3%4.3%5.5%4.1%3.3%5.7%4.5%4.5%0.8%3.5%4.7%
ROIC10.5%10.5%11.7%8.8%7.3%9.8%9.3%8.7%7.7%9.4%10.9%
ROCE14.0%14.0%14.6%11.2%9.2%12.3%11.5%11.3%10.1%11.3%12.6%

DVA Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

DaVita Inc. carries a Debt/EBITDA ratio of 5.5x, which is highly leveraged (72% above the sector average of 3.2x). Net debt stands at $14.3B ($15.0B total debt minus $758M cash). Interest coverage of 3.5x is adequate, though a cyclical earnings downturn could tighten the margin of safety.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity12.9912.995.774.055.315.053.863.192.011.581.56
Debt / EBITDA5.525.524.294.735.714.834.814.954.773.933.59
Net Debt / Equity—12.345.393.915.204.863.752.881.941.501.41
Net Debt / EBITDA5.245.244.014.575.594.654.674.464.623.723.23
Debt / FCF—10.907.697.2012.058.938.337.7112.478.817.23
Interest Coverage3.513.514.253.953.716.325.333.693.154.254.92

DVA Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

A current ratio of 1.29x means DaVita Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.19x to 1.29x over the past 3 years.

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.291.291.261.191.201.321.271.561.722.881.48
Quick Ratio1.241.241.211.131.161.281.231.511.702.821.41
Cash Ratio0.250.250.280.150.120.200.140.470.070.180.37
Asset Turnover—0.780.740.720.690.680.680.660.600.570.79
Inventory Turnover62.0062.0063.9058.1475.2374.2171.5780.8076.3242.0245.08
Days Sales Outstanding—79.1672.8572.6480.1975.7377.0773.8876.7172.6044.36

DVA Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

DaVita Inc. returns 13.4% to shareholders annually primarily through share buybacks. The earnings yield of 4.6% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield4.6%8.4%7.2%7.1%7.6%7.8%5.4%7.0%8.9%4.8%6.7%
FCF Yield9.8%13.1%11.2%15.3%13.4%10.3%9.1%11.3%8.8%7.2%8.6%
Buyback Yield13.4%17.9%10.6%2.8%11.2%12.8%10.1%20.7%13.1%5.8%8.3%
Total Shareholder Yield13.4%17.9%10.6%2.8%11.2%12.8%10.1%20.7%13.1%5.8%8.3%
Shares Outstanding—$88M$87M$93M$96M$110M$123M$154M$172M$191M$205M

Peer Comparison

Compare DVA with 10 similar companies in its peer group

CompanyMarket CapP/EEV/EBITDAP/FCFGross MarginOp MarginROEROICDebt/EBITDA
DVA logoDVAYou$13B21.910.110.227.0%14.7%46.0%10.5%5.5
FMS logoFMS$13B12.36.36.725.6%9.3%6.5%5.6%3.3
FXNC logoFXNC$265M15.06.712.674.0%19.6%10.0%7.7%1.9
UNH logoUNH$364B30.317.922.618.5%4.2%11.8%9.2%3.4
HUM logoHUM$43B36.722.9115.514.5%1.1%7.0%4.1%5.7
CNC logoCNC$30B-4.5—7.012.2%-3.9%-28.7%-21.6%—
USPH logoUSPH$964M44.613.215.820.1%10.3%2.0%5.6%4.1
AMSF logoAMSF$589M12.78.866.046.4%18.6%18.5%21.9%0.0
PNTG logoPNTG$1B39.826.744.212.9%5.4%8.6%5.6%7.6
ADUS logoADUS$2B18.112.216.932.5%9.7%9.3%8.8%1.3
BAX logoBAX$10B-11.427.231.830.1%-2.7%-14.6%-1.4%14.9
Healthcare Median—22.114.218.563.9%-4.3%-32.6%-11.6%3.2

Peer selection based on competitive and market overlap. Compare multiple stocks →

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into DVA consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DVA — Frequently Asked Questions

Quick answers to the most common questions about buying DVA stock.

What is DaVita Inc.'s P/E ratio?

DaVita Inc.'s current P/E ratio is 21.9x. The historical average is 24.7x. This places it at the 79th percentile of its historical range.

What is DaVita Inc.'s EV/EBITDA?

DaVita Inc.'s current EV/EBITDA is 10.1x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.9x.

What is DaVita Inc.'s ROE?

DaVita Inc.'s return on equity (ROE) is 46.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 22.1%.

Is DVA stock overvalued?

Based on historical data, DaVita Inc. is trading at a P/E of 21.9x. This is at the 79th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are DaVita Inc.'s profit margins?

DaVita Inc. has 27.0% gross margin and 14.7% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does DaVita Inc. have?

DaVita Inc.'s Debt/EBITDA ratio is 5.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.